30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

John Chiminski

Insider profile

Currently holds positions in Catalent Inc and Juniper Pharmaceuticals Inc

Performance

Overall performance
3.9

Performance over holding periods
3.9
30 days 90 days 120 days
Average return 22% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Chairman of the Board, Chief Executive Officer Catalent Inc Feb. 13, 2019 -
President, Chief Executive Officer Juniper Pharmaceuticals Inc Aug. 13, 2018 -
Independent Director Biogen Inc June 19, 2019 - Dec. 1, 2019
Chairman of the Board, President, Chief Executive Officer Catalent Inc Oct. 25, 2016 - Feb. 13, 2019
President, Chief Executive Officer, Director Catalent Inc March 1, 2009 - Oct. 25, 2016

John Chiminski's trades of Catalent Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-08-01 2023-08-01 PrS Proposed sale
61,408
116.13
US$1,927,170
61,408 116.13 US$1,927,170
2022-08-26 2022-08-25 S Sale
28,971 -24.7%
479.33
US$1,608,886
28,971 -24.7% 479.33 US$1,608,886
2022-07-28 2022-07-26 S Sale
72,471 +15.4%
27.52
US$3,585,522
72,471 +15.4% 27.52 US$3,585,522
2022-03-15 2022-03-11 B Purchase
18,000 +367.3%
5.18
US$93,272
18,000 +367.3% 5.18 US$93,272
2021-10-05 2021-10-01 PlS Planned sale
4,888 -3.3%
132.86
US$649,420
4,888 -3.3% 132.86 US$649,420
2021-10-05 2021-10-01 PlS Planned sale
64,031 -30.3%
132.18
US$8,463,618
64,031 -30.3% 132.18 US$8,463,618
2021-10-05 2021-10-01 PlS Planned sale
26,662 -11.2%
131.21
US$3,498,321
26,662 -11.2% 131.21 US$3,498,321
2021-10-05 2021-10-01 PlS Planned sale
21,245 -8.2%
130.39
US$2,770,136
21,245 -8.2% 130.39 US$2,770,136
2021-10-05 2021-10-01 PlS Planned sale
12,700 -4.7%
129.22
US$1,641,094
12,700 -4.7% 129.22 US$1,641,094
2021-10-05 2021-10-01 PlS Planned sale
18,510 -6.4%
128.10
US$2,371,131
18,510 -6.4% 128.10 US$2,371,131
2021-10-05 2021-10-01 PlS Planned sale
4,601 -1.6%
127.34
US$585,891
4,601 -1.6% 127.34 US$585,891
2021-03-22 2021-03-19 PlS Planned sale
800 -0.5%
107.07
US$85,656
800 -0.5% 107.07 US$85,656
2021-03-22 2021-03-19 PlS Planned sale
111,641 -40.4%
106.24
US$11,860,740
111,641 -40.4% 106.24 US$11,860,740
2021-03-22 2021-03-19 PlS Planned sale
70,583 -20.4%
105.64
US$7,456,388
70,583 -20.4% 105.64 US$7,456,388
2021-03-22 2021-03-18 PlS Planned sale
42,220 -20.5%
105.16
US$4,439,855
42,220 -20.5% 105.16 US$4,439,855
2020-10-05 2020-10-02 PlS Planned sale
173,040 -49.9%
86.05
US$14,890,092
173,040 -49.9% 86.05 US$14,890,092
2020-10-05 2020-10-02 PlS Planned sale
9,191 -2.6%
85.27
US$783,717
9,191 -2.6% 85.27 US$783,717
2019-10-09 2019-10-07 PlS Planned sale
97,043 -30.2%
48.84
US$4,739,580
97,043 -30.2% 48.84 US$4,739,580